---
figid: PMC7836472__12906_2021_3215_Fig5_HTML
figtitle: Network pharmacology perspective for deciphering potential mechanisms of
  action of Solanum nigrum L. in bladder cancer
organisms:
- Solanum nigrum
- Homo sapiens
pmcid: PMC7836472
filename: 12906_2021_3215_Fig5_HTML.jpg
figlink: pmc/articles/PMC7836472/figure/Fig5/
number: F5
caption: 'The S. nigrum pathway constructed in the present study. Abbreviations: GF,
  growth factor; RTK, receptor tyrosine kinases; EGF, epidermal growth factor; EGFR,
  epidermal growth factor receptor; ERBB2, Erb-B2 receptor tyrosine kinase 2; Ras,
  HRas & KRas proto-oncogene; Raf-1, threonine-protein kinase Raf1; Elk-1, ETS transcription
  factor ELK1; c-Myc, MYC Proto-Oncogene; c-fos, AP-1 transcription factor subunit;
  Rb, protein phosphatase 1; E2F, retinoblastoma-associated protein; PI3K, phosphoinositide
  3-kinase; mTOR, mechanistic target of rapamycin kinase; HIF-1α hypoxia-inducible
  factor 1 subunit alpha; NF-κB, nuclear factor kappa B; IκBα, NF-κB inhibitor alpha;
  AP-1, Jun & FOS proto-oncogene; Bcl-2, Bcl-2 apoptosis regulator; HK, hexokinase;
  VEGF, vascular endothelial growth factor A; eNOS, endothelial nitric oxide synthase;
  IL-6, interleukin 6; P53, tumor protein P53'
papertitle: A network pharmacology perspective for deciphering potential mechanisms
  of action of Solanum nigrum L. in bladder cancer.
reftext: Yang Dong, et al. BMC Complement Med Ther. 2021;21:45.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.956378
figid_alias: PMC7836472__F5
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7836472__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7836472__12906_2021_3215_Fig5_HTML.html
  '@type': Dataset
  description: 'The S. nigrum pathway constructed in the present study. Abbreviations:
    GF, growth factor; RTK, receptor tyrosine kinases; EGF, epidermal growth factor;
    EGFR, epidermal growth factor receptor; ERBB2, Erb-B2 receptor tyrosine kinase
    2; Ras, HRas & KRas proto-oncogene; Raf-1, threonine-protein kinase Raf1; Elk-1,
    ETS transcription factor ELK1; c-Myc, MYC Proto-Oncogene; c-fos, AP-1 transcription
    factor subunit; Rb, protein phosphatase 1; E2F, retinoblastoma-associated protein;
    PI3K, phosphoinositide 3-kinase; mTOR, mechanistic target of rapamycin kinase;
    HIF-1α hypoxia-inducible factor 1 subunit alpha; NF-κB, nuclear factor kappa B;
    IκBα, NF-κB inhibitor alpha; AP-1, Jun & FOS proto-oncogene; Bcl-2, Bcl-2 apoptosis
    regulator; HK, hexokinase; VEGF, vascular endothelial growth factor A; eNOS, endothelial
    nitric oxide synthase; IL-6, interleukin 6; P53, tumor protein P53'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB2
  - BCL2L11
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RAF1
  - RNASE3
  - NFKBIA
  - MTOR
  - MYC
  - ELK1
  - KCNH4
  - KCNH8
  - CCND1
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - BCL2
  - IL6
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - NOS3
  - ENO4
  - TP53
  - TP63
  - TP73
---
